Heptagon Life Sciences Private Limited, a active private limited company, was established on 24 March 2016 in Chennai, Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U74120TN2016PTC104911. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Employing 5 professional, Its leadership includes Sebastian Nelson Durai (Director), Kannan Thirukumaran (Director), Pushpanathan Wilson (Director). Past directors included Sebastian Nelson Durai, Kannan Thirukumaran, Sundaram Annamalai. It holds ₹3.58 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Flat G Ii, Ground Floor 'A'Block, Maha Flats No.17/19 Ali Khan Street, Ala, Ndur,, Chennai, Tamil Nadu, 600016.
U74120TN2016PTC104911
104911
24 March 2016
₹0.10 M
₹0.10 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Heptagon Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sebastian Nelson Durai | Director | 13 Jun 2019 | Current |
| Kannan Thirukumaran | Director | 13 Jun 2019 | Current |
| Pushpanathan Wilson | Director | 24 Mar 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 29 Sep 2019 | Past |
| Pramod Abcsdd | Director | 29 Sep 2019 | Past |
| Pramod Abcsdd | Director | 29 Jan 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Heptagon Life Sciences Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 79.39% increase. The company also saw a substantial improvement in profitability, with a 14.43% increase in profit. The company's net worth observed a substantial decline by a decrease of 62.77%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Heptagon Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹3,575,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jun 2020 | Canara Bank | ₹0.58 M | Open |
| 02 Mar 2018 | Canara Bank | ₹3.00 M | Open |
Explore comprehensive loan charge details -
Heptagon Life Sciences has a workforce of 5 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Heptagon Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Heptagon Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Heptagon Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Heptagon Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was recorded as a recent event.
Progress on A charge with Canara Bank amounted to Rs. 0.58 M with Charge ID 100396486 was registered on 24 Jun 2020. was documented.
The activity Sebastian Nelson Durai was appointed as a Director was appointed as a Director on 13 Jun 2019 & has been associated with this company since 6 years 6 months . was completed.
Kannan Thirukumaran was appointed as a Director was appointed as a Director on 13 Jun 2019 & has been associated with this company since 6 years 6 months . was recorded as a recent event.
Progress on A charge with Canara Bank amounted to Rs. 3.00 M with Charge ID 100185603 was registered on 02 Mar 2018. was documented.
The CIN of Heptagon Life Sciences Private Limited is U74120TN2016PTC104911.
Heptagon Life Sciences Private Limited is headquartered at Flat G Ii, Ground Floor 'A'Block, Maha Flats No.17/19 Ali Khan Street, Ala, Ndur,, Chennai, Tamil Nadu, 600016.
Heptagon Life Sciences Private Limited was incorporated on 24 March 2016.
The current directors of Heptagon Life Sciences Private Limited are
The primary industry of Heptagon Life Sciences Private Limited is Pharma.
Heptagon Life Sciences Private Limited is unlisted.
The authorized capital of Heptagon Life Sciences Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Heptagon Life Sciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX